drugset / Trial / NCT06092983
A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383
RandomizedSequentialDouble-blindTreatment
Summary
This study will investigate the safety, tolerability and pharmacokinetics of ascending multiple doses of HS-10383 in healthy subjects using a randomized, double blind, placebo controlled, single center study design.
Timeline
- Start
- 2023-06-14
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10383 | Unknown | 50 mg | Oral |
| Subject | HS-10383 | Unknown | 150 mg | Oral |
| Subject | HS-10383 | Unknown | 300 mg | Oral |
| Subject | HS-10383 | Unknown | 450 mg | Oral |
Indications
No indication recorded.